December 13, 2022
December 13, 2022
Categories

Immunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Blinatumomab regimen may lead to ā€˜diminishing use of transplantā€™ for B-ALL subgroup (study E1910)

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
December 11, 2022
December 11, 2022
Categories

Press Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressiveā€”yet highly curableā€”acute promyelocytic leukemia (APL)

Do you like it?
Read more
December 6, 2022
December 6, 2022
Categories

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

Do you like it?
Read more
October 28, 2022
October 28, 2022
Categories

Press Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting

Do you like it?
Read more
March 25, 2022
March 25, 2022
Categories

Press Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success

Do you like it?
Read more
March 16, 2022
March 16, 2022
Categories

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

Do you like it?
Read more
June 3, 2018
June 3, 2018
Categories

Press Release: TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

Do you like it?
Read more
ECOG-ACRIN Cancer Research Group